The Supreme Court grappled with the complex bankruptcy reorganization of Purdue Pharma, the opioid manufacturer, which includes a provision shielding the Sackler family from future liability.
A Missouri jury has ordered Bayer to pay $1.56 billion to four plaintiffs who asserted that the company's Roundup weedkiller led to injuries, including cancer.
Drogueria Betances, LLC, one of Puerto Rico's major pharmaceutical drug distributors, has been ordered to pay $12 million following allegations of failing to report numerous suspicious orders for controlled substances, as stated by the U.S. Justice Department.
A groundbreaking decision by a jury has resulted in a man being granted a remarkable $6.19 million in compensation for the traumatic brain injury (TBI) he sustained, which led to a brain hemorrhage while he was under the care of Firelands Hospital.
The Harris County Attorney has announced a settlement in the county's lawsuit against Altria Group, Inc., Philip Morris USA, Inc., and related companies regarding their deceptive marketing of Juul e-cigarette products to minors.
Indivior Inc., a pharmaceutical company, has announced a $385 million settlement in an antitrust lawsuit related to its opioid addiction treatment Suboxone.
Johnson & Johnson (J&J) is considering initiating bankruptcy proceedings for its talc unit for the third time as part of an effort to advance an $8.9 billion settlement for thousands of claims alleging that J&J's baby powder caused cancer and mesothelioma.
Johnson & Johnson is experiencing a significant increase, of at least 28%, in new lawsuits alleging that its talc-based baby powder causes cancer.
In a legal case in Fleming County, a woman who has been battling stage four breast cancer for over eight years was granted a verdict of more than $7 million in damages.
A recent study has established a crucial link between a specific protein released in response to asbestos exposure and the development of mesothelioma, shedding light on the long-sought-after mechanism behind this deadly cancer.
Bankrupt pharmaceutical company Mallinckrodt is reportedly in discussions with major investors regarding the potential sale of some or all of its business divisions, which may result in its withdrawal from the opioid industry.
According to recently disclosed data, the amount of prescription opioid tablets transported into the United States in the second half of the 2010s fell significantly, even as the overdose epidemic in the country grew worse.